Hydrolytic deamination of 5-methylcytosine leads to the formation of G/T mismatches. We have shown previously that these G/T mispairs are corrected to G/C pairs by a mismatch-specific thymine-DNA glycosylase, TDG, which we subsequently purified from human cells. Here we describe the cloning of the human cDNA encoding TDG. We have identified two distinct cDNA species that differ by 100 nucleotides at the 3-untranslated region. These cDNAs contain a 410-amino acid open reading frame that encodes a 46-kDa polypeptide. The G/T glycosylase, expressed both in vitro and in Escherichia coli, migrated in denaturing polyacrylamide gels with an apparent size of 60 kDa. The substrate specificity of the recombinant protein corresponded to that of the cellular enzyme, and polyclonal antisera raised against the recombinant protein neutralized both activities. We therefore conclude that the cDNA described below encodes human TDG. Data base searches identified a serendipitously cloned mouse cDNA sequence that could be shown to encode the murine TDG homologue. No common amino acid sequence motifs between the G/T-specific enzyme and other DNA glycosylases could be found, suggesting that TDG belongs to a new class of baseexcision repair enzymes.
The process of spontaneous hydrolytic deamination affects all DNA bases with exocyclic amino groups (Lindahl, 1982) . The rates of deamination vary, such that adenine is converted to hypoxanthine (H) 1 approximately 1 order of magnitude slower than cytosine to uracil (U). In double-stranded DNA, the latter deamination processes give rise to H/T and U/G mispairs, which, if uncorrected prior to replication, give rise to A 3 G and C 3 T transition mutations in the progeny DNA, respectively. All organisms have evolved repair enzymes that remove these deaminated bases with high efficiency. Thus, cytosine deamination is countered by uracil glycosylase (Lindahl, 1982 for review; Dianov and Lindahl, 1994) , and the removal of hypox-anthine is mediated by 3-methyladenine DNA-glycosylase (Saparbaev and Laval, 1994) .
In organisms that methylate cytosine, the deamination process affects also 5-methylcytosine residues, which are converted to thymine and thus give rise to G/T mispairs. This process appears to proceed with kinetics slightly faster than that of the C 3 U conversion (Ehrlich et al., 1986) , but, in addition to being mutagenic by giving rise to C 3 T transition mutations (Duncan and Miller, 1980) , it also brings about a change in the pattern of DNA methylation, which may, in turn, result in altered gene expression or any other phenomenon associated with or controlled by this important epigenetic process (Hergersberg, 1991) . Given the potential importance of 5-methylcytosine deamination in vertebrates, we set out to search for a repair mechanism dedicated to the correction of this type of damage, i.e. an enzymatic system capable of correcting G/T mispairs to G/C pairs. In our initial studies, using mismatchcarrying SV40 heteroduplexes transfected into monkey cells, we found strong evidence for the existence in these cells of a specific mismatch repair process, dedicated to G/T 3 G/C correction Jiricny, 1987, 1988) . We were subsequently able to detect this process in cell-free extracts, using mismatchcontaining oligonucleotide heteroduplexes (Wiebauer and Jiricny, 1989 ) and were later able to show that the initial step of the correction is mediated by a mismatch-specific thymine-DNA glycosylase (Wiebauer and Jiricny, 1990) . The enzyme was purified to apparent homogeneity from HeLa cells (Neddermann and Jiricny, 1993) and was then subjected to a limited biochemical characterization (Neddermann and Jiricny, 1994) . The latter study revealed that the enzyme possesses a relatively broad substrate specificity in vitro, in that it was able to excise thymine not only from mispairs with guanine, but also from other T-containing mispairs. Moreover, it could excise also uracil and 5-bromouracil from mismatches with guanine. Work from other laboratories substantiated and considerably extended our findings. Thus Day and co-workers (Sibghat-Ullah and Day, 1992) and Karran and colleagues (Griffin et al., 1994) showed that the enzyme present in crude extracts processed also 6-O-methylguanine/thymine mispairs by excising the thymine. The same workers also showed that the enzyme is sensitive to the sequence context of the mispair (Griffin and Karran, 1993; Day, 1993, 1995) . Given the many capabilities of the enzyme in vitro, it is not easy to state with any certainty which, if any, of these enzymatic reactions reflect the true physiological function of the protein. Clearly, this potential anomaly can only be resolved by looking at the phenotype of a cell in which the G/T repair function is missing. As such a cell or organism is unavailable at present, we may need to create such a system by constructing knock-out cell lines and animal models. The first steps toward the achieve-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank TM /EMBL Data Bank with accession number(s) U51166.
¶ To whom correspondence should be addressed. ment of this goal, namely the cloning and expression of the G/T mismatch-specific glycosylase from HeLa cells, are described below.
EXPERIMENTAL PROCEDURES
All reagents were of analytical grade purity. Restriction enzymes were used according to the instructions of the manufacturers. HeLa cells were grown at 37°C and 5% CO 2 in Dulbecco's modified Eagle's medium containing 5% fetal calf serum. All DNA sequences are written in the 5Ј to 3Ј direction.
Preparation of Total HeLa Cell cDNA-HeLa cell monolayers in 150-mm diameter dishes were incubated with 7.5 ml of lysis buffer (0.1 M Tris/HCl, pH 7.5, 4 M guanidinium thiocyanate, 0.1 M ␤-mercaptoethanol) for 15 min at room temperature. The lysed cells were then layered onto 4.5 ml of CsCl solution (5.7 M CsCl in 25 mM sodium citrate, pH 5.0) and centrifuged for 24 h at 36,000 rpm in a Beckman SW40 rotor at 22°C. The RNA pellet was resuspended in 300 l of diethylpyrocarbonate-treated water and reprecipitated once with EtOH. It was then dried and resuspended in 100 l of diethylpyrocarbonate-treated water.
Reverse transcription of RNA was carried out with 800 units of Moloney murine leukemia virus-reverse transcriptase, 4 g of total HeLa RNA, 100 pmol of oligo (dT) 12 MN (M: G, A, C and N: G, A, T, C) in 20 l of 10 mM DTT, 50 mM Tris/HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , and 0.2 mM of each deoxynucleoside triphosphate. The mixture was heated for 10 min at 70°C before the addition of DTT and enzyme and subsequently incubated for 1 h at 37°C. The enzyme was inactivated by heating for 5 min at 95°C.
Protein Sequencing-The G/T glycosylase, purified as described (Neddermann and Jiricny, 1993) , was loaded onto a 12% SDS-polyacrylamide gel. Following staining with Coomassie Blue, the band corresponding to the 55-kDa polypeptide was cut out of the gel, and the protein was digested in the gel with alkylated trypsin (Promega Corp. U. K.). The tryptic peptides were recovered by sequential extractions and separated by tandem high performance liquid chromatography on a Hewlett-Packard 1090 M with diode-array detection. Anion-exchange and octadecyl reverse phase columns were connected in series, essentially as described (Kawasaki and Suzuki, 1990) . Fractions were collected and applied directly to an Applied Biosystems 477A pulsed-liquid automated sequencer modified as described (Totty et al., 1992) .
Cloning of the Full-length cDNA Encoding the G/T DNA Glycosylase-All PCR primers derived from amino acid sequences were fully degenerate. Restriction sites were added at the 5Ј-end of each primer to facilitate cloning. The procedure described by Lingner et al. (1991) was applied. Primers P1s (CCGAATTCATGGCNGA(A/G)GCNCC) and P1a (CCGTCGACAC(C/T)TC(C/T)TCNGGCAT) were designed to yield a nondegenerate nucleotide sequence coding for the internal part of PEP1. The PCR reaction contained 10 mM Tris/HCl, pH 8.3, 50 mM KCl, 2.5 mM MgCl 2 , 0.2 g of HeLa cDNA, and 125 pmol of each primer in a total volume of 100 l. Following a denaturation step of 5 min at 95°C, deoxynucleoside triphosphates at 150 M each and 1.5 units of Taq DNA polymerase (Boehringer) were added. The PCR reaction was carried out for 30 cycles at 94°C for 30 s and 53°C for 20 s. Similarly, P2s (CCGAATTCTG(C/T)(C/T)TNTT(C/T)ATG) and P2a (CCGTCGAC(A/G)-TTNA(A/G)(C/T)TGNAC) were designed in order to obtain the internal nondegenerate nucleotide sequence coding for the internal part of PEP2. The PCR reaction was performed as described above, except that 350 pmol of primers, 4 mM MgCl 2 , and an annealing temperature of 45°C were used. The DNA fragments coding for PEP1 and PEP2 were then digested with EcoRI and SalI, agarose gel-purified, and cloned into the EcoRI/SalI sites of pGEM-3Zf(ϩ) plasmid, thus creating plasmids pGemP1 and pGemP2, respectively.
The DNA fragment between PEP1 and PEP2 was amplified using 100 pmol of primers P3s (AATATGGCAGTTGTGAATGAACAGCAA) and P4a (CCGTCGACGTTTAGTTGGACCTCACTGAGCCCTGACAT), designed with the unambiguous cDNA sequences encoding the respective peptides obtained in the experiment above. The reaction was carried out for 30 cycles at 94°C for 1 min and at 72°C for 2 min in the presence of 3 mM MgCl 2. The resulting DNA fragment, F447, was cloned into the SmaI site of pGem-3Zf(ϩ) to give plasmid (pGemF447). P3s did not contain additional restriction sites whereas P4a contained a SalI site at its 5Ј-end.
The DNA fragment F447 was first used as a specific probe in the screening of Lambda ZAP II HeLa cDNA library (Stratagene). About 10 6 plaque-forming units were screened using the protocol supplied by the manufacturer. Two positive phage, 1 and 14, were identified and analyzed further. The pBluescript SK(Ϫ) vectors containing the cDNA inserts were rescued to give the constructs phTDG-1 and phTDG-14, respectively. phTDG-1 was shown by sequencing to contain the 88 N-terminal amino acid residues (including PEP1), as well as 400 bp of the 5Ј-untranslated region. phTDG-14 contained a 693-bp insert encoding PEP2-PEP5, but no 3Ј-untranslated region. This clone also did not overlap with phTDG-1. We therefore screened a second cDNA library, Lambda Uni-ZAP. After in vivo excision of the positive pBluescript SK(Ϫ) phagemids, the library clones were further screened by PCR, using the primers P5s (CCGTCGACGTTAAGAACTTGGAATTTGGG-CTTCAG) and M13 forward (GTAAAACGACGGCCAGT). This process identified two clones, phTDG-2 with an insert of 2,200 bp, and phTDG-3 with an insert of 2,100 nucleotides. See Fig. 1c for relative location of the inserts.
Construction of a Recombinant Plasmid Coding for the Full-length G/T Glycosylase-The clone coding for the full-length protein was constructed as follows. phTDG-1 was digested with DdeI, the fragment containing the insert was purified on a 0.8% low-melting agarose gel and digested with EcoRI. In parallel, pGemF447 was digested with SalI. The SalI fragment containing the insert was then partially digested with DdeI in order to yield a 380-bp fragment, which represented the insert cleaved only at position 548. In a two-step ligation reaction, the 550-bp EcoRI/DdeI fragment isolated from phTDG-1 and the 380-bp DdeI/SalI fragment from pGemF447 were ligated into the EcoRI/SalI sites of pGEM-3Zf(ϩ). This new vector, pGem-2, contained a fusion of clone 1 and F447. In the next step, the insert of pGem-2 was fused to clone 14. pGem-2 was first digested with PvuII, and the insert-containing fragment was partially digested with DdeI in order to get a fragment of 1024 bp, which represented the insert cleaved only at position 901. This fragment was then digested with EcoRI to give a smaller, 900-bp fragment. In parallel, phTDG-14 was first digested with PstI and SalI. The insert was partially digested with DdeI, and the fragment cleaved at position 901 was gel-purified. The EcoRI/DdeI fragment of pGem-2 and the DdeI/SalI fragment of phTDG-14 were cloned into the EcoRI/SalI sites of pGEM-3Zf(ϩ). The new vector containing the fusion of clone phTDG-1, F447, and clone phTDG-14 was named pGem-3. The DNA fragment containing the 3Ј-end of the coding region could be obtained by PCR amplification of the clone phTDG-2, using standard conditions and the primers P6s (CTCTGCTATGTTATGCCATCATC-CAGTG) and P7a (CCGTCGACTTAAGCATGGCTTTCTTCTTCCTG). The resulting PCR fragment was digested with XhoI and SalI and cloned in pGem-3 previously digested with the same enzymes to finally obtain the construct phTDG. The nucleotide sequence of the final construct was compared with the sequences of the individual clones obtained from the library to ensure that no PCR-generated mutations were included. Sequencing was performed by the dideoxynucleotide chain-termination method using Sequenase Version 2.0 (U. S. Biochemical Corp.).
Northern Blot Analysis-10 g of HeLa cell total RNA and 2 g of poly (A) ϩ RNA purified from 70 g of total RNA using Dynabeads Oligo(dT) (DYNAL) and following the manufacturer's protocol were resuspended in formamide loading buffer and separated on a 1% formaldehyde-agarose gel as described (Sambrook et al., 1982) . The positions of the 28 S and 18 S rRNAs were determined by inspection on an UV transilluminator, and the gel was blotted for 16 h in 20 ϫ SSC on a GeneScreen nylon membrane (DuPont NEN). The filter was rinsed in 2 ϫ SSC, baked under vacuum for 1 h at 80°C, and cross-linked for 30 s using a Stratalinker (Stratagene). Pre-hybridization was performed in 0.5 M NaH 2 PO 4 , pH 7.2, 7% SDS, and 1 mM EDTA for 2 h at 65°C. Hybridization was carried out for 12 h at 65°C in the above buffer containing 1 ϫ 10 6 cpm/ml of the random-primed labeled F447 gelpurified fragment. After one wash at room temperature and two washes at 65°C for 10 min each in 50 mM NaH 2 PO 4 , pH 7.2, and 1% SDS, the filter was air-dried and autoradiographed.
In Vitro Transcription and Translation Reactions-The mouse cDNA coding region contained as a GAL4 fusion in the plasmid pC87 (a kind gift of D. Nathans) was excised by NcoI and HincII digestion and inserted in the pCITE-1 expression vector (Novagen) digested with NcoI and EcoRV. The resulting construct pCITEmTDG was linearized with XbaI and used as template in in vitro transcription reactions. The phTDG construct described above was linearized either with SalI to produce the full-length human protein or with BglII to produce a C-terminal truncated polypeptide of 201 amino acids, referred to as ⌬hTDG. The linearized plasmids were transcribed in vitro with T7 RNA polymerase (Stratagene) as described by the manufacturer. The transcripts were either boiled for 5 min prior to use or directly translated using nuclease-treated rabbit reticulocyte lysates (Promega). All translation reactions were carried out in a final volume of 30 l in the presence of 3 g of cRNA, 0.4 mM MgCl 2 , 66 mM potassium acetate, and 12 l of rabbit reticulocyte lysate. Translation mixtures were incubated at 30°C for 90 min with [ 35 S]methionine (1000 Ci/mmol, 10 mCi/ml, Amersham Corp.) and 3 M amino acid mix lacking methionine. Samples of the translation mixtures were either loaded onto a 12% SDSpolyacrylamide gel for autoradiography of the labeled proteins or used directly in nicking assays.
Construction of a pT7.7 Plasmid Containing the Full-length G/T Glycosylase ORF-A DNA fragment containing the entire G/T glycosylase ORF was obtained by PCR amplification of the phTDG plasmid using 100 pmol of M13 reverse primer and P8 primer CCTCTAGAAT-GGAAGCGGAGAACGCGGGC. The amplified product was digested at the 5Ј-end with XbaI followed by Klenow filling-in reaction and with SalI at the 3Ј-end. The purified 1232-bp fragment was inserted in the pT7.7 vector digested with SmaI and SalI. The resulting construct, pT7-hTDG, was sequenced using Sequenase Version 2.0 (U. S. Biochemical Corp.) and used for the expression in bacteria of the G/T glycosylase polypeptide. The N terminus of the recombinant protein contains eight amino acid residues derived from the vector (MARIRAPR) prior to the first natural in-frame methionine.
Expression and Purification of pT7-TDG Protein in BL21 Bacterial Cells-The pT7-hTDG plasmid was transformed into the Escherichia coli strain BL 21 (DE3) as described (Studier et al., 1990) . A 10-liter liquid culture derived from a single colony was grown at 37°C to A 600 ϭ 0.9. It was then cooled to 22°C and induced with 600 M IPTG (isopropyl-␤-thiogalactopyranoside) for 5 h at 22°C. Bacterial pellets were collected by centrifugation, washed with 25 mM Hepes pH 7.6, 1 mM EDTA (HE buffer), frozen at Ϫ20°C, and resuspended in 400 ml of HE buffer containing 10% glycerol, 1 mM PMSF, and 1 mM DTT. Cells were lysed through two passages in the French press at 4°C, brought to 0.1 M NaCl, and centrifuged at 15,000 ϫ g for 30 min. The 400-ml supernatant containing about 90% of the recombinant protein was incubated with 200 ml of a DEAE-Sepharose Fast Flow resin (Pharmacia) preequilibrated with 5 volumes of HE buffer containing 10% glycerol, 0.1 M NaCl, 1 mM PMSF, and 1 mM DTT. Stepwise elution with 0.1, 0.5, and 1 M NaCl in the same buffer yielded the protein in the 0.5 M NaCl fraction (400 ml). This was dialyzed against 4 liters of HE buffer containing 10% glycerol, 0.1 M NaCl, 1 mM PMSF, and 1 mM DTT. The dialyzed sample was adsorbed batchwise onto a 50 ml of S Sepharose Fast Flow (Pharmacia) equilibrated with the same buffer, and the TDG protein was eluted with 0.5 M NaCl (100 ml). This fraction was diluted to 0.2 M NaCl with 150 ml of HE buffer containing 10% glycerol, 1 mM DTT, and loaded on a Resource-S 6-ml FPLC cartridge (Pharmacia). After washing with 10 volumes of 0.2 M NaCl buffer, stepwise elution with 0.3, 0.5, and 1 M NaCl was performed, the protein eluting with 0.3 M NaCl (6 ml). The sample was diluted to 0.1 M NaCl with an equal volume of HE buffer containing 10% glycerol and 1 mM DTT and loaded on a Mono-Q FPLC column (Pharmacia). After a wash with 5 ml of the 0.1 M NaCl buffer, a 0.1-0.5 M NaCl linear gradient (25 min, 0.5 ml/min) was applied, followed by a 1 M NaCl step (1 min). The protein peak was detected in fractions containing approximately 0.3 M NaCl.
Production of Polyclonal Antibodies, Immunoblot Analysis, and Immunofluorescence-The FPLC-purified protein (1 mg) was used for immunization of a New Zealand White S.P.F. female rabbit (Charles River) according to standard protocols. Both the preimmune serum and the polyclonal antiserum were purified on protein A-Sepharose (Pharmacia) as described (Harlow and Lane, 1988) . Immunoblot analyses and immunofluorescence were performed as described (Sambrook et al., 1982) .
Enzymatic Activity Assays-The enzymatic activities of the recombinant protein or of the polypeptide present in HeLa nuclear extracts were monitored by means of a "nicking assay," as described previously (Neddermann and Jiricny, 1993) . Briefly, the mismatch-containing 90or 34-mer oligonucleotide duplexes (40 fmol) were incubated with 25 g of HeLa nuclear extract, 3 l of the in vitro translation mixture, or 40 ng of the pure recombinant protein expressed in E. coli. The reactions were performed in 25 mM Hepes pH 7.8, 0.5 mM EDTA, 0.5 mM DTT in a total volume of 25 l at 30°C for 16, 3, and 1 h, respectively. After the incubation, the reactions were stopped by proteinase K digestion, extracted once with phenol/chloroform, and the DNA was recovered by ethanol precipitation. When the recombinant protein was tested, the dried DNA pellet was solubilized in 4 l of 0.1 N NaOH and incubated at 90°C for 30 min to cleave the oligonucleotide at the AP site prior to separation on a denaturing polyacrylamide gel. In the substrate specificity experiments, the neighboring base 5Ј to the G or the m6G involved in the mismatch was either a C or a G. In the antibody neutralization studies, reactions were performed in the absence or presence of preimmune serum or of the specific antiserum under the conditions described above.
RESULTS

Peptide Microsequencing of the Human Mismatch-specific
Thymine-DNA Glycosylase-The protein was purified from 900 g of HeLa cells as described previously (Neddermann and Jiricny, 1993) . The total yield of the nearly homogeneous 55-kDa polypeptide was approximately 45 g. Partial proteolysis of the pure TDG with trypsin (see "Experimental Procedures") yielded five peptides, arbitrarily named PEP1-5. These were subjected to microsequencing, and the N-terminal residues of these peptides were as follows: PEP1, MAEAPNMAVVNEQQ-MPEEVPA; PEP2, CLFMSGLSEVQLN; PEP3, YGIGFTNMV-ER; PEP4, NLEFGLQP(L or H)K; PEP5, IPDTETLCYVMPS.
PCR-mediated Cloning of the ORF Encoding the G/T Glycosylase-Retro-translation of the above peptide sequences into DNA yielded a highly degenerate set of oligonucleotides, none of which was judged sufficiently specific for the screening of cDNA libraries. We therefore decided to adopt the strategy described by Lingner et al. (1991) , whereby degenerate oligonucleotides complementary to the ends of a selected peptide are used as PCR primers in the amplification of a cDNA fragment encoding the respective peptide (see "Experimental Procedures"). This strategy yielded the DNA sequence encoding PEP1, where the central 28 nucleotides could be unambiguously assigned. Using the same technology with PEP2, we were able to obtain a unique sequence of 15 nucleotides, which encoded the central five amino acid residues of PEP2. PCRcloning primers P3s and P4a, respectively, were designed on the basis of these sequences and used to amplify the cDNA between PEP1 and PEP2. This experiment yielded a 447-bp TDG fragment, F447 (Fig. 1c) .
The F447 cDNA segment was used as a probe in the screening of a Lambda ZAP II HeLa cDNA library (Stratagene). Two positive phage were identified, and the respective pBluescript SK(Ϫ) plasmids were rescued and sequenced. phTDG-1 contained 400 nucleotides of the 5Ј-untranslated region and a 265-bp stretch encoding the N-terminal 88 amino acid residues. The fact that PEP1 was found within this fragment confirmed the authenticity of the clone. phTDG-14 contained a 693-bp insert, which did not overlap with the N-terminal sequence of TDG, but which contained PEP2, PEP3, PEP4, and PEP5. In order to obtain the 3Ј-end of the G/T glycosylase cDNA, the F447 fragment was used to screen a new, unidirectional HeLa cDNA library, Lambda Uni-ZAP (Stratagene). A number of positive clones were identified by PCR amplification of the inserts using the DNA primers P6s and M13 forward (see "Experimental Procedures"). One clone, which gave an amplified fragment of 2,200 bp (phTDG-2), was sequenced and found to contain the poly(A) tail, a polyadenylation signal, a 1,776-bp 3Ј-untranslated region and the coding sequence up to PEP5. Together, the three lambda clones contained almost all of the TDG cDNA, with the exception of the gap between clones phTDG-1 and phTDG-14. As this 89-bp stretch was present in the F447 fragment, we could construct the entire cDNA sequence of hTDG (Fig. 1) , as summarized in Fig. 1c .
Northern blot analysis of HeLa total and poly(A) ϩ RNAs confirmed that the G/T DNA glycosylase mRNA migrates with an apparent size of 3.3-3.4 kilobases (Fig. 1b) , which indicates that the sequence in Fig. 1a represents the entire cDNA of the human TDG.
The analysis of the positive clones containing the 3Ј-region of the cDNA revealed that the clones fell into two distinct families (Fig. 1c) . One consisted of clones with the sequence AGTAAA 22 nucleotides upstream from the first adenine of the poly(A) tail. The other family of molecules was 100 nucleotides longer at the 3Ј-end, whereby the poly(A) tail was preceded by a perfect polyadenylation signal sequence, AATAAA, 23 nucle-otides upstream. Closer examination of the nucleotide sequence around the upstream polyadenylation sequence revealed a termination signal sequence GTGTG, 31 nucleotides downstream from the AGTAAA motif, suggesting that these signals were used in the premature termination of the mRNA synthesis and in subsequent polyadenylation. Indeed, AGUAAA is the third most efficiently recognized motif in polyadenylation of mRNA, after AAUAAA and AUUAAA (Sheets et al., 1990) . Due to the difference of only 100 nucleotides in the lengths of the two mRNA species, we could not estimate their relative abundance from Northern blot analysis. However, judging by the similar abundance of the short and the long clones in the Lambda Uni-ZAP cDNA library, the premature termination/polyadenylation of the G/T glycosylase mRNA cannot be considered an infrequent event.
In summary, the entire sequence of the G/T glycosylase cDNA is shown in Fig. 1a . The full-length cDNA contains a 400-bp 5Ј-untranslated region, an open reading frame of 1232 bp with a coding capacity of 410 amino acids, and two classes of 3Ј-untranslated regions of 1676 and 1776 bp, respectively (Fig. 1c) .
Interestingly, databank searches with the human TDG peptide sequence identified a murine polypeptide (PIR accession number A46132), encoded by a cDNA clone JZA-3, which displayed an 88% identity (92% homology) at the amino acid level with TDG (Fig. 2) . The clone was originally identified during a search for proteins capable of interacting with c-Jun in a twohybrid assay (Chevray and Nathans, 1992) but was subsequently discarded for lack of selectivity. We show below that the protein encoded by JZA-3 is the murine homologue of the human TDG.
Expression of the G/T Glycosylase in Cell-free Extracts-The three cDNA clones, phTDG-1, phTDG-14, and phTDG-2, together with the F447 fragment were used to construct the expression vector, phTDG, containing the entire G/T-specific thymine-DNA glycosylase open reading frame. The phTDG plasmid and a vector pCITEmTDG (encoding the murine enzyme) were used as templates in a T7 RNA polymerase-dependent in vitro transcription (see "Experimental Procedures"). The synthesized RNA was translated in a rabbit reticulocyte lysate in the presence of [ 35 S]methionine to give proteins of molecular mass around 60 kDa on SDS-PAGE (Fig. 3a) . The lysates containing both the human and the murine polypeptides possessed G/T glycosylase activity (Fig. 3b) , which was absent from control translations using a C-terminal deletion mutant p⌬hTDG of the human glycosylase. This finding confirms the expectation that the phTDG clone encodes the human G/T mismatch-specific thymine-DNA glycosylase and that the clone pCITEmTDG encodes its murine homologue. Both the in vitro translated polypeptides migrated in SDS-PAGE gels with a molecular mass slightly larger than the 55-kDa enzyme purified from HeLa cells (Neddermann and Jiricny, 1993) , which implies that the latter polypeptide was either degraded during purification or generated by alternative initiation (see also "Discussion"). In any case, both the proteins migrate through polyacrylamide gels in an anomalous fashion, as the ORF of the human enzyme encodes a polypeptide of 410 amino acid residues, with a calculated molecular mass of only 46 kDa and the 421 amino acid mouse protein has a calculated molecular mass of 46.85 kDa.
Expression of the G/T Glycosylase in E. coli-The 1232-bp fragment containing the entire G/T glycosylase open reading frame was subcloned into the pT7.7 bacterial expression vector, and the resulting construct pT7hTDG was transfected into competent E. coli strain BL21 (DE3), which contains the T7 polymerase gene under the control of an IPTG-inducible promoter. Following an exponential growth phase at 37°C, the expression of the T7 polymerase was induced with IPTG for 3 h at 37°C. Crude lysates of the induced cells contained a band at 60 kDa on SDS-PAGE, which was absent from the uninduced control culture. As the overexpressed protein was present predominantly in inclusion bodies (data not shown), we investigated the possibility of inducing the expression of the recombinant protein at different temperatures. The highest amount of soluble protein was produced upon induction at 22°C (Fig. 4a) and, despite the fact that the overall yield was nearly 10 times lower than when induction was carried out at 37°C, we decided to induce the protein at the lower temperature. The recombinant protein was purified from 10 liters of culture by chromatography on DEAE-Sepharose Fast Flow, S-Sepharose Fast Flow, Resource-S and Mono-Q FPLC columns to yield 5 mg of protein consisting predominantly of the 60 kDa species (Fig.   FIG. 2. 
Alignment of the amino acid sequences of the human (hTDG) and murine (mTDG) G/T glycosylases.
Note the near-identity of the central portions of the two enzymes and the 11amino acid insertion in the murine sequence. FIG. 1. mRNA, cDNA, and protein sequence analysis of the human TDG. a, complete cDNA and peptide sequence of the human TDG. The tryptic peptides identified by microsequencing are boxed. b, Northern blot analysis of total and poly(A) ϩ HeLa RNA using F447 DNA as a probe. The predicted size of TDG mRNA was 3.3-3.4 kb. c, schematic representation of the two mRNA species encoding TDG. The open reading frame is located between nucleotides 400 and 1632. Numbers above the line represent amino acid residues, and those below the line indicate nucleotides. The shorter species terminates at nucleotide 3309. The termination is due to the termination signal GUGUG and polyadenylation due to the imperfect signal AGUAAA. The longer messenger RNA terminates at nucleotide 3409, and the polyadenylation signal is a perfect consensus AAUAAA. The cDNA fragments identified by lambda library screening (phTDG-1, phTDG-14, phTDG-2) and by PCR (F447) are shown as stippled bars. 4b). All fractions contained also the 55-kDa protein, which was confirmed by Western blot analysis (Fig. 5a) to originate from the TDG protein (see also "Discussion").
Substrate Specificity of the Purified Bacterial Recombinant Protein-Had the enzyme evolved to counter the damage brought about by hydrolytic deamination of 5-methylcytosine, it might demonstrate a preference for G/T mispairs arising in CpG sequences. Previous studies (Griffin and Karran, 1993; Day, 1993, 1995) have addressed this question by studying the processing in HeLa extracts of G/T mispairs in various sequence contexts. Our present data confirm their findings, inasmuch as the recombinant enzyme does indeed show a significant preference for G/T mispairs in a CpG context (Fig. 4c) . Interestingly, the enzyme is also capable of processing mismatches between thymine and 6-O-methylguanine, whereby it generates an apyrimidinic site opposite the modified guanine. Also in this case, TDG preferentially addresses 6-O-methyl G/T mispairs when the neighboring base 5Ј to the 6-O-methyl G is a C rather than a G. This data does not support the involvement of this enzyme in the repair of lesions caused by alkylating agents, which most frequently modify the second G in a GpG context (see also "Discussion").
Generation of Rabbit Polyclonal Antibodies and Immunocharacterization of TDG-Rabbits were immunized with the purified recombinant protein as described under "Experimental Procedures." When the polyclonal antisera were used in immunoblotting experiments, we could show that they reacted with three bands, a major one at 60 kDa and a doublet around 55 kDa (Fig. 5a) . The former represents the full-length G/T glycosylase, whereas the smaller polypeptides derive either from proteolytic degradation or from alternative translation starting at one of the downstream methionines (see also "Discussion").
Addition of the antiserum to the G/T in vitro repair reaction significantly reduced processing of the mispair by the recombinant protein (Fig. 5b, lower panel) as well as by the enzymatic activity present in the cell extracts (Fig. 5b, upper panel) . The Lanes 1 and 2, translation in rabbit reticulocyte lysates of hTDG mRNA; lanes 3 and 4, control reaction; translations of a hTDG deletion mutant ⌬hTDG; lanes 5 and 6, translation of the mRNA encoding the murine TDG. The translation reactions were carried out in the presence of [S 35 ]methionine. The template RNA was either used directly from T7-mediated transcription (lanes 1, 3, and 5) or was first denatured by boiling (lanes 2, 4, and 6) . The figure is an autoradiogram of a denaturing SDS-polyacrylamide gel. b, enzymatic activity of the in vitro translated proteins on G/C (lane 1) or G/T substrates. Lanes 2 and 3, nicking of G/T substrate by hTDG; lanes 4 and 5, control reactions show that the hTDG mutant ⌬hTDG has no enzymatic activity, and the G/T-specific nicking activity is absent from reticulocyte lysates; lanes 6 and 7, the murine TDG homologue has similar G/T processing activity to the human TDG. Lanes 1, 3, 5, and 7, controls. latter results suggest that TDG is the only enzyme present in the HeLa nuclear extracts capable of processing G/T mispairs in the oligonucleotide substrate.
In indirect immunofluorescence studies, we could show that the antiserum reacts with a nuclear protein, as would be expected for a DNA repair factor (Fig. 5c ).
DISCUSSION
The molecular cloning of the cDNA encoding the mismatchspecific thymine-DNA glycosylase (TDG) confirmed that this enzymatic activity is indeed novel, rather than being solely an additional property of a previously characterized DNA repair protein. The TDG mRNA could be translated both in vitro and in vivo to yield a polypeptide of an apparent molecular mass of 60 kDa, which was shown to possess the same enzymatic activity and substrate specificity as the protein present in HeLa cell extracts ( Figs. 3 and 4 ; see also Griffin and Karran, 1993; Griffin et al., 1994; Jiricny, 1993, 1994; Sibghat-Ullah and Day, 1992 . Rabbit polyclonal antiserum raised against the recombinant polypeptide could neutralize the processing of G/T mispairs by both, the human protein contained in HeLa cell extracts and by the recombinant protein ( Fig. 5b) , providing thus further evidence that the TDG enzymatic activity is encoded by our cDNA clone and that it is the only activity in human cells responsible for G/T processing. Immunofluorescence studies showed the protein to be localized predominantly in the nucleus (Fig. 5c ). In Western blotting experiments, the antiserum reacted with the 60-kDa polypeptide as well as with two smaller species of around 55 kDa. This suggests that the protein isolated from HeLa cells by conventional chromatography (Neddermann and Jiricny, 1993 ) was a proteolytically degraded form of the full-length enzyme. However, we cannot exclude the possibility that the 55-kDa species is the product of translation that initiates at one of the downstream methionines. Among the tryptic peptides originating from the digestion of the purified HeLa enzyme, the sequence of PEP1 is atypical, in that it begins with a methionine not preceded by a basic amino acid such as arginine or lysine. This might be an indication that PEP1 is in fact an N-terminal peptide of one of the shorter forms of TDG. Whether this truncated form arose by proteolytic degradation or by alternative initiation, we cannot say at present. Indeed, the methionine indicated as residue 26 in our sequence (Fig. 1a) is not in an ideal Kozak sequence context, which might argue against it acting as an alternative translation start site. On the other hand, the aberrant 55-kDa forms of TDG are found both in human and bacterial cell extracts, suggesting that proteases of similar specificity ought to be involved in the degradation of the full-length protein in both organisms. Moreover, inclusion of a mixture of protease inhibitors during the purification failed to yield an undegraded protein, arguing against proteolysis as the reason for the appearance of the shorter forms. To date, we were unable to obtain experimental evidence in support of either hypothesis. Direct N-terminal sequencing of the overproduced TDG was attempted without success, suggesting that the N terminus of all the forms is blocked (not shown). Clearly, more detailed study is required to clarify this point.
Analysis of the amino acid sequence of TDG failed to reveal any similarity with other known DNA glycosylases. This suggests that TDG evolved separately from the other species, probably only when the necessity for this activity arose. Thus, enzymes responsible for the repair of hydrolytic deamination such as uracil glycosylase were required as much in the primordial organisms with very small DNA genomes as in mammals, and their sequence conservation pays witness to this fact (uracil glycosylase displays 56% identity between E. coli and man) (Seeberg et al., 1995) . In contrast, cytosine methylation appeared only in vertebrates and in plants, which came much later on the evolutionary scale. As no existing activity could apparently be adapted to cope with the mutagenic load caused by 5-methylcytosine deamination, a new enzyme has evolved.
The murine and human TDG cDNA sequences displayed extensive homology. The mouse clone was isolated from a cDNA library during a two-hybrid system search for proteins that interact with the leucine zipper motif of c-Jun (Chevray and Nathans, 1992) but was later discarded due to its lack of specificity. Transcription and translation of the murine cDNA clone (a generous gift of D. Nathans) yielded a protein of the expected molecular size, which was shown to possess TDG activity (Fig. 3) . Moreover, the murine cDNA clone was used in the isolation of a mouse genomic clone, which is currently being employed in the generation of transgenic animals. Alignment of the amino acid sequences of the murine and the human TDG FIG. 5. Anti-hTDG polyclonal antibody localizes the protein to the nucleus and neutralizes the enzymatic activity. a, immunoblotting of hTDG present in HeLa cell extracts. The TDG-specific rabbit polyclonal antiserum reacts with the mature full-length protein that migrates with an apparent molecular size of 60 kDa, as well as with the smaller hTDG form (see text). The highest molecular weight band was demonstrated to be nonspecific (data not shown) b, the polyclonal antiserum can neutralize both, the G/T glycosylase activity present in HeLa extracts (upper panel), as well as the recombinant enzyme (lower panel). Lanes 1, nicking assay; lanes 2, nicking assay in the presence of rabbit preimmune serum; lanes 3, nicking assay in the presence of TDG-specific antiserum. For conditions see "Experimental Procedures." c, indirect immunofluorescence experiment, showing that TDG is localized predominantly in the nucleus of HeLa cells. The anti-hTDG rabbit polyclonal antiserum was used as the primary antibody and rhodaminelabeled goat anti-rabbit polyclonal antiserum as the secondary antibody.
proteins is shown in Fig. 2 . The two sequences display an 88% identity and a similarity of 92%, whereby the conservation is higher still when no account is made of the 11-amino acid insertion in the murine protein. We are currently generating antibodies against this region, as they promise to be among the few analytical tools capable of distinguishing between the two proteins.
The experiments reported to date provided solely circumstantial evidence that TDG has indeed evolved specifically for the correction of deamination damage due to hydrolysis of 5-methylcytosine. However, the recombinant protein could be shown to address preferentially G/T mispairs in the context of a CpG dinucleotide (Fig. 4c) , the only sequence frequently methylated in vertebrate DNA. It would thus appear that the G/T mispair in a CpG context is indeed the real substrate of the TDG enzyme. Interestingly, the recombinant enzyme is capable of processing mismatches between thymine and 6-O-methylguanine in vitro. This phenomenon was also observed previously (Sibghat-Ullah and Day, 1992; Griffin et al., 1994) , and it had been suggested that the erroneous processing of these lesions may contribute to the cytotoxic effect of methylating agents. This is unlikely in our opinion, as the first line of defense against alkylating agents in mammalian cells is the removal of the alkyl group from the 6-position of guanine by an alkylguanine transferase (see Friedberg et al., 1995 for reviews) . Cells deficient in this activity become hypersensitive to alkylating agents, presumably due to the action of post-replicative mismatch repair on the 6-O-methylguanine/thymine mispairs. This hypothesis was substantiated by the finding that some alkylguanine transferase-deficient but alkylation-resistant clones could be shown to be deficient in post-replicative mismatch repair (Karran and Bignami, 1994) . In contrast, the TDG enzyme levels appear to be normal in all the alkylationresistant lines examined to date (data not shown), which implies that this enzyme in not involved in the alkylation-mediated cytotoxic effects. Our biochemical data also provide additional evidence against the role of TDG in the repair of alkylation damage, inasmuch as the enzyme preferentially addresses 6-O-methyl G/T mispairs in a CpG context, rather than in the context of a GpG dinucleotide, the latter being the most frequently modified sequence by alkylating agents (Zarbl et al., 1985) .
No human disease has so far been shown to segregate with a TDG deficiency. This is in itself not surprising, as cells lacking this activity might be expected to have no phenotype other than displaying an elevated rate of C 3 T transitions in CpG dinucleotides. Clearly then, the TDG deficiency would reveal itself only in cases where such a transition has resulted in the mutation of a gene that is capable of altering the phenotype of the cell. It is interesting to note in this context that nearly 50% of cancer-associated mutations in the p53 gene are C 3 T transitions in CpG dinucleotides (Greenblatt et al., 1994) . The presence of such mutations is not in itself evidence of malfunctioning TDG, as the G/T repair process does not appear to function in vivo with a 100% efficiency (Brown and Jiricny, 1987) . However, cancers with C 3 T transitions in p53 must be the prime target tissue to search for TDG anomalies.
